MapLight Therapeutics, Inc. (MPLT)
13.02
+0.02
(+0.19%)
USD |
NASDAQ |
Sep 14, 10:11
MapLight Therapeutics Total Liabilities (Quarterly) : 20.05M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.05M |
| March 31, 2026 | 18.95M |
| December 31, 2025 | 21.14M |
| September 30, 2025 | 23.71M |
| Date | Value |
|---|---|
| June 30, 2025 | 20.36M |
| March 31, 2025 | 18.57M |
| June 30, 2024 | |
| March 31, 2024 | 19.75M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 1.661B |
| Cullinan Therapeutics, Inc. | 42.03M |
| Apogee Therapeutics, Inc. | 141.21M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 368.35M |
| Shareholders Equity (Quarterly) | 348.30M |
| Debt to Equity Ratio | 0.0057 |
| Current Ratio | 16.52 |
| Net Debt Paydown Yield | 0.05% |